1.
Thromb Haemost
; 122(2): 300-303, 2022 02.
Article
in English
| MEDLINE | ID: covidwho-1597511
Subject(s)
Ad26COVS1/adverse effects , Carotid Artery Thrombosis/chemically induced , Ischemic Stroke/chemically induced , Thrombocytopenia/chemically induced , Thrombosis/chemically induced , Vaccination/adverse effects , Ad26COVS1/administration & dosage , Amaurosis Fugax/chemically induced , Anticoagulants/therapeutic use , Carotid Artery Thrombosis/diagnostic imaging , Carotid Artery Thrombosis/drug therapy , Humans , Ischemic Stroke/diagnostic imaging , Ischemic Stroke/drug therapy , Male , Middle Aged , Recurrence , Syndrome , Thrombocytopenia/diagnosis , Thrombosis/diagnostic imaging , Thrombosis/drug therapy
2.
Cureus
; 12(11): e11305, 2020 Nov 02.
Article
in English
| MEDLINE | ID: covidwho-951083
ABSTRACT
The novel coronavirus SARS-CoV-2, which causes the disease commonly known as COVID-19, has spread around the world, associated mostly with respiratory tract symptoms. We report the first case of a thyrotoxic crisis precipitated by COVID-19 and describe its identification, diagnosis, and management in the emergency unit. We also conduct a systematic review of thyrotoxic crisis literature and COVID-19 infection. This case highlights the importance of considering the SARS-CoV2 virus as a potential trigger of a thyroid storm. It also shows the need to maintain extreme contact precautions even after one month of COVID-19 symptom onset.